Classic Technique Reveals HIV in Action

REVELATION: The glycoprotein gp120 binds to the CD4 receptor on the T cell, causing the viral molecule to contort in a way that enables it to bind to the nearby chemokine receptor, too. This dual binding of HIV to two co-receptors triggers fusion of the viral and T cell membranes. Infection begins. X-ray crystallography has played a pivotal role in life science research, from providing data crucial to deciphering the DNA double helix, to revealing the structure of HIV protease. Now, the techn

Written byRicki Lewis
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

REVELATION: The glycoprotein gp120 binds to the CD4 receptor on the T cell, causing the viral molecule to contort in a way that enables it to bind to the nearby chemokine receptor, too. This dual binding of HIV to two co-receptors triggers fusion of the viral and T cell membranes. Infection begins.
X-ray crystallography has played a pivotal role in life science research, from providing data crucial to deciphering the DNA double helix, to revealing the structure of HIV protease. Now, the technology has glimpsed the complex choreography that precedes HIV infection: the viral surface glycoprotein gp120 binding the CD4 receptor on a vulnerable T cell. And the dance is more complex than immunologists had thought.

"The virus uses a complicated set of mechanisms to target the cell and trigger a reaction to fuse the viral and cell membranes. The crystal structure doesn't completely reveal the mechanism of the conformational ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies